AMAM logo

Ambrx Biopharma (AMAM) Earnings Per Share

Annual EPS

-$0.29
+$0.19+39.58%

December 31, 2022

Summary

Performance

1-Year Change

+39.58%

3-Year Change

+21.3%

5-Year Change

+21.3%

15-Year Change

+21.3%

AMAM EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

-$1.38
AMAM annual earnings per share is currently -78.99% lower than the consensus analysts' forecast

High & Low

All-time High

-$0.29
AMAM annual earnings per share is currently at an all-time high

3-Year Low

-$0.48

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
AMAM previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
AMAM next annual earnings announcement has not yet been scheduled

OtherAMAMprofitabilitymetrics:

Annual Revenue

$7.40 M
AMAM annual revenue is $7.40 million

Annual Gross Profit

-
AMAM annual gross profit value is unknown

Annual Operating Profit

-$66.74 M
AMAM annual operating income is -$66.74 million

Annual Net Income

-$78.00 M
AMAM annual net profit is -$78.00 million

Quarterly EPS

-$0.37
-$0.32-640.00%

September 1, 2023

Summary

Performance

3-Month Change

-640%

1-Year Change

+7.5%

3-Year Change

-

5-Year Change

-

AMAM Quarterly EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

-$0.40
AMAM quarterly earnings per share is currently -7.50% lower than the consensus analysts' forecast

High & Low

All-time High

-$0.04

3-Year Low

-$0.40

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2023
AMAM previous earnings announcement was published on Sep 1, 2023

Next Quarterly Earnings Report Date

N/A
AMAM next earnings announcement has not yet been scheduled

OtherAMAMprofitabilitymetrics:

Quarterly Revenue

$53.00 K
AMAM quarterly revenue is $53.00 thousand

Quarterly Gross Profit

-
AMAM quarterly gross profit value is unknown

Quarterly Operating Profit

-$25.63 M
AMAM quarterly operating income is -$25.63 million

Quarterly Net Income

-$22.99 M
AMAM quarterly net profit is -$22.99 million

TTM EPS

-$0.51
+$0.03+5.55%

September 1, 2023

Summary

Performance

3-Month Change

+5.55%

1-Year Change

+13.49%

3-Year Change

-

5-Year Change

-

AMAM TTM EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

-$0.87
AMAM TTM earnings per share is currently -41.33% lower than the consensus analysts' forecast

High & Low

All-time High

-$0.08

3-Year Low

-$0.63

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2023
AMAM previous earnings announcement was published on Sep 1, 2023

Next Quarterly Earnings Report Date

N/A
AMAM next earnings announcement has not yet been scheduled

OtherAMAMprofitabilitymetrics:

Annual Revenue

$7.40 M
AMAM annual revenue is $7.40 million

Annual Gross Profit

-
AMAM annual gross profit value is unknown

Annual Operating Profit

-$66.74 M
AMAM annual operating income is -$66.74 million

Annual Net Income

-$78.00 M
AMAM annual net profit is -$78.00 million

EPS Formula

EPS =  
Net Income - Preferred Dividends
Shares Outstanding

Annual EPS

-$0.29
AMAM annual earnings per share is -$0.29

Annual Net Income

-$78.00 M
AMAM annual net profit is -$78.00 million

Shares Outstanding

63.15 M
AMAM shares outstanding is 63.15 million

AMAM EPS Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+39.6%+7.5%+13.5%
3 y3 years+21.3%--
5 y5 years+21.3%--

AMAM EPS Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+65.5%+815.8%+8.1%+538.0%+23.5%
5 y5-yearat high+65.5%+815.8%+8.1%+538.0%+23.5%
alltimeall timeat high+65.5%+815.8%+8.1%+538.0%+23.5%

Ambrx Biopharma EPS History

DateAnnualQuarterlyTTM
Sep 2023
-
-$0.37(+640.0%)
-$0.51(-5.6%)
Jun 2023
-
-$0.05(0.0%)
-$0.54(-10.0%)
Mar 2023
-
-$0.05(+23.8%)
-$0.60(-4.8%)
Dec 2022
-$0.29
-$0.04(-89.9%)
-$0.63(+6.8%)
Sep 2022
-
-$0.40(+263.6%)
-$0.59(+210.5%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$0.11(+37.5%)
-$0.19(+137.5%)
Mar 2022
-
-$0.08
-$0.08
Dec 2021
-$0.48(+57.9%)
-
-
Dec 2020
-$0.30(-17.5%)
-
-
Dec 2019
-$0.37
-
-

FAQ

  • What is Ambrx Biopharma annual earnings per share?
  • What is the all time high annual EPS for Ambrx Biopharma?
  • What is Ambrx Biopharma annual EPS year-on-year change?
  • What is Ambrx Biopharma quarterly earnings per share?
  • What is the all time high quarterly EPS for Ambrx Biopharma?
  • What is Ambrx Biopharma quarterly EPS year-on-year change?
  • What is Ambrx Biopharma TTM earnings per share?
  • What is the all time high TTM EPS for Ambrx Biopharma?
  • What is Ambrx Biopharma TTM EPS year-on-year change?

What is Ambrx Biopharma annual earnings per share?

The current annual EPS of AMAM is -$0.29

What is the all time high annual EPS for Ambrx Biopharma?

Ambrx Biopharma all-time high annual earnings per share is -$0.29

What is Ambrx Biopharma annual EPS year-on-year change?

Over the past year, AMAM annual earnings per share has changed by +$0.19 (+39.58%)

What is Ambrx Biopharma quarterly earnings per share?

The current quarterly EPS of AMAM is -$0.37

What is the all time high quarterly EPS for Ambrx Biopharma?

Ambrx Biopharma all-time high quarterly earnings per share is -$0.04

What is Ambrx Biopharma quarterly EPS year-on-year change?

Over the past year, AMAM quarterly earnings per share has changed by +$0.03 (+7.50%)

What is Ambrx Biopharma TTM earnings per share?

The current TTM EPS of AMAM is -$0.51

What is the all time high TTM EPS for Ambrx Biopharma?

Ambrx Biopharma all-time high TTM earnings per share is -$0.08

What is Ambrx Biopharma TTM EPS year-on-year change?

Over the past year, AMAM TTM earnings per share has changed by +$0.08 (+13.49%)